Felix Urman, MD
General Practice · Somerset, NJNPI 1902844210
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.5%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by BD at 53.5% of the total. Among general practice clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $46.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BD$990
- Teladoc Health, Inc.$300
- AbbVie$128
- Novartis$124
- Sun Pharmaceutical Industries Inc.$60
- Galderma Laboratories, L.p.$56
- plus $193 from 8 others
What the payments were for
- Consulting fees$99053%
- Speaking & faculty fees$30016%
- Food & beverage$56130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BD | 1 | $990 |
| Teladoc Health, Inc. | 1 | $300 |
| AbbVie | 9 | $128 |
| Novartis | 7 | $124 |
| Sun Pharmaceutical Industries Inc. | 4 | $60 |
| Galderma Laboratories, L.p. | 4 | $56 |
| Regeneron Healthcare Solutions, Inc. | 4 | $55 |
| Lilly USA, LLC | 2 | $28 |
| Johnson & Johnson | 2 | $28 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $27 |
| Sanofi | 1 | $15 |
| Biofrontera Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| UCB, Inc. | 1 | $13 |
How this compares
$1,851 in reported general payments places this provider in the 90th percentile of 2,978 general practice providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 95 | $7,602 |
| Fluorouracil | 21 | $1,781 |
| CiclopiroxCiclopirox Olamine | 31 | $1,058 |
| Metronidazole | 15 | $930 |
| Clindamycin Phosphate | 13 | $906 |
| Ketoconazole | 16 | $659 |
| Minocycline Hcl | 15 | $611 |
| Triamcinolone Acetonide | 36 | $445 |
| Mupirocin | 23 | $145 |
| Hydroxyzine Hcl | 12 | $127 |
Paid to pharmacies, not to this prescriber.
Other general practice in Somerset
- Jeffrey ChustckieSomerset$165K
- Ryan LakeClark$914K
- Hua-Yu Steven LiaoLodi$816K
- Howard GlazerFort Lee$636K
- John MinichettiEnglewood$142K
- Narenderan RajanHackettstown$135K
- Cindy YeungPiscataway$111K
- Andrew SpectorHaworth$75K
- Paul GoodmanPennington$42K
- Steven RasnerBridgeton$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.